CNTA (CNTA)
Centessa Pharmaceuticals plc
NASDAQ:CNTAHealthcare · Biotechnology
+1.17%$40.50
Mkt Cap-
Float30.31M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$15M
Net Income-$197.53M
Total Assets$687.5M
Free Cash Flow-$194.19M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$7.57M
Total Equity$526.86M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in CNTA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$687.5M
Liabilities$160.63M
Accounts Receivable$60.34M
Accounts Payable$7.58M
Inventory$0
PP&E (Net)$10.85M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $15M | $0 | $6.85M | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $15M | $0 | $6.85M | $0 | $0 | $0 | $0 |
| Gross Margin | 100.0% | - | 100.0% | - | - | - | - |
| Research and Development | $172.22M | $150.24M | $124.41M | $155.08M | $96.32M | $9.3M | $4.26M |
| Selling, General, and Administrative | $50.47M | $50.81M | $53.73M | $55.2M | $43.01M | $1.14M | $790K |
| Other | $0 | $0 | $0 | $1.98M | $235.54M | $0 | $0 |
| Total Operating Expenses | $222.69M | $201.06M | $178.14M | $212.26M | $374.87M | $10.44M | $5.05M |
| Operating Income (EBIT) | -$207.69M | -$201.06M | -$171.28M | -$212.26M | -$374.87M | -$10.44M | -$5.05M |
| Operating Margin | -1384.6% | - | -2499.4% | - | - | - | - |
| Interest Expense | $11.46M | $10.09M | $9.91M | $7.28M | $2.55M | $378K | $118K |
| Interest Income | $20.53M | $14.02M | $10.48M | $244K | $0 | $0 | $0 |
| Other Income (Expense) | $11.98M | -$31.86M | -$4.86M | -$4.69M | -$6.92M | -$223K | -$8K |
| Income Before Tax (EBT) | -$195.71M | -$232.91M | -$176.14M | -$216.95M | -$381.79M | -$10.66M | -$5.06M |
| Income Tax Expense | $1.82M | $2.84M | -$25.06M | -$747K | $114K | $0 | $0 |
| Net Income | -$197.53M | -$235.76M | -$151.09M | -$216.21M | -$381.9M | -$10.66M | -$5.28M |
| Net Income Margin | -1316.9% | - | -2204.7% | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -1.46 | -2.06 | -1.57 | -2.31 | -4.24 | -0.08 | -0.05 |
| Diluted EPS | -1.46 | -2.06 | -1.57 | -2.31 | -4.24 | -0.08 | -0.05 |
| Weighted Average OS | 135.72M | 114.47M | 96.18M | 93.40M | 89.99M | 70.89M | 106.47M |
| EBITDA | -$183.33M | -$221.88M | -$165.43M | -$209.55M | -$139.3M | -$10.29M | -$5.05M |
| EBITDA Margin | -1222.2% | - | -2413.9% | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $61.3M | $383.22M | $128.03M | $393.64M | $595.08M | $7.23M |
| Short-Term Investments | $233.28M | $98.96M | $128.52M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $294.58M | $482.18M | $256.55M | $393.64M | $595.08M | $7.23M |
| Accounts Receivable | $60.34M | $45.3M | $39.15M | $26.72M | $16.81M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.83M | $1.78M | $1.62M | $3.27M | $993K | $3.93M |
| Total Current Assets | $367.88M | $536.41M | $315.09M | $437.75M | $628.77M | $11.16M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $10.85M | $11.76M | $12.95M | $1.17M | $162K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $282.55M | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $24.78M | $26.59M | $29.65M | $3.51M | $0 | $0 |
| Other Long-Term Assets | $1.44M | $2.05M | $2.55M | $1.88M | $699K | $552K |
| Total Long-Term Assets | $319.62M | $40.39M | $45.15M | $6.56M | $861K | $552K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $687.5M | $576.8M | $360.25M | $444.31M | $629.63M | $11.72M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $7.58M | $7.14M | $11.81M | $13.84M | $8.06M | $1.03M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $5.63M |
| Current Income Tax Payable | $0 | $835K | $112K | $1.58M | $769K | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $35.35M | $10.18M | $839K | $7.95M | $4.97M | $922K |
| Total Current Liabilities | $42.94M | $58M | $39.38M | $38.34M | $24.64M | $8.62M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $7.57M | $108.94M | $75.7M | $69.8M | $75.7M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $110.12M | $29K | $29K | $0 | $37.74M | $0 |
| Total Long-Term Liabilities | $117.7M | $117.25M | $84.62M | $69.8M | $113.44M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $160.63M | $175.25M | $124M | $108.14M | $138.08M | $8.62M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $405K | $359K | $273K | $265K | $252K | $25.55M |
| Retained Earnings | -$1.19B | -$988.7M | -$752.95M | -$601.86M | -$385.65M | -$23.84M |
| Comprehensive Income & Other | $2.71M | $4.21M | $1.49M | -$1.5M | $688K | $572K |
| Other Stockholders' Equity | $1.71B | $1.39B | $988.92M | $937.76M | $876.96M | $1.4M |
| Total Equity | $526.86M | $401.55M | $236.24M | $336.17M | $491.55M | $3.1M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $687.5M | $576.8M | $360.25M | $444.31M | $629.63M | $11.72M |
| Supplementary Data | ||||||
| Total Debt | $7.57M | $117.23M | $84.59M | $69.8M | $75.7M | $5.63M |
| Net Debt | -$53.73M | -$266M | -$43.44M | -$323.84M | -$519.38M | -$1.6M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$197.53M | -$235.76M | -$151.09M | -$216.21M | -$381.85M | -$10.66M | -$5.06M |
| Depreciation & Amortization | $921K | $942K | $810K | $131K | $34K | $0 | $6K |
| Deferred Income Tax | $2.51M | $2.65M | -$26.53M | -$2.86M | $0 | $0 | $770 |
| Stock-Based Compensation | $30.96M | $33.55M | $29.39M | $24.96M | $0 | $336K | $236K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $2.91M | -$6.6M | -$12.09M | -$11.71M | -$6.72M | -$1.46M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $2.96M | -$4.58M | -$2.72M | $6.35M | $0 | -$49K | $855K |
| Other Working Capital | -$57.11M | $33.29M | -$4.04M | $2.53M | $1.34M | $1.02M | -$1.86M |
| Total Working Capital Change | -$51.24M | $22.1M | -$18.86M | -$2.83M | -$5.38M | -$489K | -$1.01M |
| Other Non-Cash Items | $20.56M | $34.46M | $5.93M | -$3.75M | $251.06M | $186K | -$770 |
| Net Cash from Operating | -$193.82M | -$142.06M | -$160.34M | -$200.55M | -$136.14M | -$10.63M | -$5.83M |
| Investing Activities | |||||||
| Capital Expenditures | -$371K | -$34K | -$169K | -$1.14M | -$186K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $63.43M | $0 | $0 |
| Purchases of Investments | -$739.76M | -$140.53M | -$264.91M | $0 | $0 | $0 | $0 |
| Sales of Investments | $321.6M | $171.83M | $138.07M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $206K | $0 | $0 | $0 |
| Net Cash from Investing | -$418.53M | $31.27M | -$127M | -$931K | $63.25M | $0 | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | $762K | - | - | -$73.64M | -$1.36M | -$3.83M |
| Common Stock Issuance | $296.72M | $359.61M | $20.81M | $718K | $586.44M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | -$12K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$5.19M | $5.91M | $310K | -$261K | $0 | $1K | $6K |
| Net Cash from Financing | $291.53M | $364.75M | $21.12M | $457K | $660.07M | $1.36M | $9.01M |
| Forex Effect | -$448K | $1.23M | $615K | -$418K | $2.9M | -$75K | $520K |
| Net Change in Cash | -$321.27M | $255.19M | -$265.61M | -$201.44M | $590.08M | -$9.34M | $3.7M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$193.82M | -$142.06M | -$160.34M | -$200.55M | -$136.14M | -$10.63M | -$5.83M |
| Capital Expenditure | -$371K | -$34K | -$169K | -$1.14M | -$186K | $0 | $0 |
| Free Cash Flow | -$194.19M | -$142.09M | -$160.51M | -$201.68M | -$136.33M | -$10.63M | -$5.83M |
| Cash at Beginning | $383.22M | $128.03M | $393.64M | $595.08M | $5M | $16.57M | $12.87M |
| Cash at End | $61.95M | $383.22M | $128.03M | $393.64M | $595.08M | $7.23M | $16.57M |